BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 16288025)

  • 21. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
    Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
    Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.
    Porcile C; Bajetto A; Barbero S; Pirani P; Schettini G
    Ann N Y Acad Sci; 2004 Dec; 1030():162-9. PubMed ID: 15659794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
    Runnebaum IB; Brüning A
    Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
    Naylor MS; Stamp GW; Foulkes WD; Eccles D; Balkwill FR
    J Clin Invest; 1993 May; 91(5):2194-206. PubMed ID: 8387543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
    Yuecheng Y; Xiaoyan X
    Eur J Cancer Prev; 2007 Oct; 16(5):430-5. PubMed ID: 17923814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells.
    Muthukumaran N; Miletti-González KE; Ravindranath AK; Rodríguez-Rodríguez L
    Mol Cancer Res; 2006 Aug; 4(8):511-20. PubMed ID: 16908592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
    Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
    Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation.
    Croitoru-Lamoury J; Guillemin GJ; Boussin FD; Mognetti B; Gigout LI; Chéret A; Vaslin B; Le Grand R; Brew BJ; Dormont D
    Glia; 2003 Mar; 41(4):354-70. PubMed ID: 12555203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
    Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
    Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
    Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS
    J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
    Airoldi I; Raffaghello L; Piovan E; Cocco C; Carlini B; Amadori A; Corrias MV; Pistoia V
    Clin Cancer Res; 2006 Jan; 12(1):77-82. PubMed ID: 16397027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O; Nazarova N; Tuohimaa P
    Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.